These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022 [TBL] [Abstract][Full Text] [Related]
3. Mouse endosialin, a C-type lectin-like cell surface receptor: expression during embryonic development and induction in experimental cancer neoangiogenesis. Rupp C; Dolznig H; Puri C; Sommergruber W; Kerjaschki D; Rettig WJ; Garin-Chesa P Cancer Immun; 2006 Jul; 6():10. PubMed ID: 16875435 [TBL] [Abstract][Full Text] [Related]
4. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839 [TBL] [Abstract][Full Text] [Related]
5. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin. Dolznig H; Schweifer N; Puri C; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P Cancer Immun; 2005 Aug; 5():10. PubMed ID: 16076089 [TBL] [Abstract][Full Text] [Related]
6. Expression of stromal cell markers in distinct compartments of human skin cancers. Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310 [TBL] [Abstract][Full Text] [Related]
7. Cell surface tumor endothelial markers are conserved in mice and humans. Carson-Walter EB; Watkins DN; Nanda A; Vogelstein B; Kinzler KW; St Croix B Cancer Res; 2001 Sep; 61(18):6649-55. PubMed ID: 11559528 [TBL] [Abstract][Full Text] [Related]
8. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Christian S; Winkler R; Helfrich I; Boos AM; Besemfelder E; Schadendorf D; Augustin HG Am J Pathol; 2008 Feb; 172(2):486-94. PubMed ID: 18187565 [TBL] [Abstract][Full Text] [Related]
9. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. Becker R; Lenter MC; Vollkommer T; Boos AM; Pfaff D; Augustin HG; Christian S FASEB J; 2008 Aug; 22(8):3059-67. PubMed ID: 18490383 [TBL] [Abstract][Full Text] [Related]
10. Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature. Kontseková S; Ohradanova Repic A; Polčicová K; Tuomaala P; Pastorek J; Pastoreková S; Parkkila S; Baráthová M Int J Oncol; 2012 Oct; 41(4):1365-72. PubMed ID: 22824847 [TBL] [Abstract][Full Text] [Related]
11. Endosialin: molecular and functional links to tumor angiogenesis. Kontsekova S; Polcicova K; Takacova M; Pastorekova S Neoplasma; 2016; 63(2):183-92. PubMed ID: 26774137 [TBL] [Abstract][Full Text] [Related]
12. Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling. Rouleau C; Smale R; Fu YS; Hui G; Wang F; Hutto E; Fogle R; Jones CM; Krumbholz R; Roth S; Curiel M; Ren Y; Bagley RG; Wallar G; Miller G; Schmid S; Horten B; Teicher BA Int J Oncol; 2011 Jul; 39(1):73-89. PubMed ID: 21537839 [TBL] [Abstract][Full Text] [Related]
13. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931 [TBL] [Abstract][Full Text] [Related]
14. Potential role of vascular targeted therapy to combat against tumor. Chen B; Jin H; Wu K Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038 [TBL] [Abstract][Full Text] [Related]
15. The potential of new tumor endothelium-specific markers for the development of antivascular therapy. Li JL; Harris AL Cancer Cell; 2007 Jun; 11(6):478-81. PubMed ID: 17560330 [TBL] [Abstract][Full Text] [Related]
16. Gene alterations in tumor-associated endothelial cells from endometrial cancer. Du XL; Jiang T; Zhao WB; Wang F; Wang GL; Cui M; Wen ZQ Int J Mol Med; 2008 Nov; 22(5):619-32. PubMed ID: 18949382 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells. Zheng PP; van der Weiden M; Kros JM J Pathol; 2005 Feb; 205(3):408-14. PubMed ID: 15682433 [TBL] [Abstract][Full Text] [Related]
18. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363 [TBL] [Abstract][Full Text] [Related]
20. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy. Ngan BY; Forte V; Campisi P Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]